Keywords
Essential thrombocythemiaMyelofibrosisPolycythemia veraMedicineContext (archaeology)Myeloproliferative neoplasmHematocritBone marrowInternal medicineGastroenterologyBiology
Affiliated Institutions
Related Publications
Masked polycythemia Vera (mPV): Results of an international study
We examined the baseline features and clinical outcomes of 140 patients presenting with JAK2V617F positivity and a bone marrow morphology conforming with WHO criteria of polycyt...
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
Abstract Controversy persists regarding the role of histopathology in the distinction between essential thrombocythemia (ET) and early-prefibrotic primary myelofi-brosis (PMF) p...
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
Pre-MF is a presentation mode of PMF with a very indolent phenotype. The major consequences of this contention is a new clinical vision of PMF, and the need to improve prognosis...
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
Key Points Noninferiority of anagrelide in comparison with hydroxyurea in WHO-essential thrombocythemia, a phase 3 trial
Publication Info
- Year
- 2015
- Type
- review
- Volume
- 5
- Issue
- 8
- Pages
- e337-e337
- Citations
- 119
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
119
OpenAlex
Cite This
Tiziano Barbui,
J. Thiele,
Alessandro M. Vannucchi
et al.
(2015).
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
Blood Cancer Journal
, 5
(8)
, e337-e337.
https://doi.org/10.1038/bcj.2015.64
Identifiers
- DOI
- 10.1038/bcj.2015.64